PCV104 - BETA-BLOCKERS, ANGIOTENSIN II, AND ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN PATIENTS WITH HEART FAILURE. DIFFERENCES IN PRESCRIPTION BY GENDER, SOCIOECONOMIC STATUS AND COMORBIDITY AFTER A FIRST HOSPITALIZATION FOR HEART FAILURE ...
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.649
https://www.valueinhealthjournal.com/article/S1098-3015(18)33949-4/fulltext
Title :
PCV104 - BETA-BLOCKERS, ANGIOTENSIN II, AND ANGIOTENSIN-CONVERTING ENZYME INHIBITORS IN PATIENTS WITH HEART FAILURE. DIFFERENCES IN PRESCRIPTION BY GENDER, SOCIOECONOMIC STATUS AND COMORBIDITY AFTER A FIRST HOSPITALIZATION FOR HEART FAILURE ...
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33949-4&doi=10.1016/j.jval.2018.09.649
First page :
Section Title :
Open access? :
No
Section Order :
65